Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Healthy Volunteers (a small group of 5 people):
- You are 19 years of age or older
- You do not have any known major health conditions, including cancer, heart disease, diabetes, high blood pressure, high cholesterol, stroke, breathing problems, or arthritis
- People of all racial and ethnic backgrounds and genders are welcome to apply
Pancreatic Cancer Patients:
- You are 19 years of age or older
- You have been diagnosed with locally advanced pancreatic cancer that has been confirmed by a biopsy (a tissue sample test)
- People of all racial and ethnic backgrounds and genders are welcome to apply
Who may not be able to join:
- You have any known major health problems (applies to healthy volunteers)
- You have any condition or implant that makes it unsafe for you to have an MRI scan (confirm with trial site)
- You are currently on kidney dialysis or are experiencing sudden kidney failure, due to risk of a serious skin and organ condition from the MRI contrast dye used
- You are currently pregnant or breastfeeding
- You are able to father a child but are not willing to use birth control during and for 6 months after the study
- You are able to become pregnant but have not been using effective birth control before starting the study, unless pregnancy is not possible due to surgery or another medical reason
- You are not willing to continue using effective birth control (such as pills, patch, IUD, condom, diaphragm with spermicide, or abstinence) for 6 months after completing the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Harrison Kim, PhD, Ohio State University
Phone: 614-293-8315
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reproducibility of quantitative DCE-MRI measurement with MRI 1.; Reproducibility of quantitative DCE-MRI measurement with MRI 2.; Reproducibility of quantitative DCE-MRI measurement with MRI 3.; Measure change in blood flow within the pancreatic cancer as measured by the P4.; Measure change in blood flow within the pancreatic cancer as measured by the P4.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.